Cargando…
Transposon-triggered innate immune response confers cancer resistance to the blind mole rat
Blind mole rats (BMRs) are small rodents, characterized by exceptionally long lifespan (> 21 years) and resistance to both spontaneous and induced tumorigenesis. Here we report that cancer resistance in the BMR is mediated by retrotransposable elements (RTEs). BMR cells and tissues express very l...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488014/ https://www.ncbi.nlm.nih.gov/pubmed/34556881 http://dx.doi.org/10.1038/s41590-021-01027-8 |
_version_ | 1784578061672382464 |
---|---|
author | Zhao, Yang Oreskovic, Ena Zhang, Quanwei Lu, Quan Gilman, Abbey Lin, Yifei S. He, Junyue Zheng, Zhizhong Lu, J. Yuyang Lee, Jina Ke, Zhonghe Ablaeva, Julia Sweet, Matthew Horvath, Steve Zhang, Zhengdong Nevo, Eviatar Seluanov, Andrei Gorbunova, Vera |
author_facet | Zhao, Yang Oreskovic, Ena Zhang, Quanwei Lu, Quan Gilman, Abbey Lin, Yifei S. He, Junyue Zheng, Zhizhong Lu, J. Yuyang Lee, Jina Ke, Zhonghe Ablaeva, Julia Sweet, Matthew Horvath, Steve Zhang, Zhengdong Nevo, Eviatar Seluanov, Andrei Gorbunova, Vera |
author_sort | Zhao, Yang |
collection | PubMed |
description | Blind mole rats (BMRs) are small rodents, characterized by exceptionally long lifespan (> 21 years) and resistance to both spontaneous and induced tumorigenesis. Here we report that cancer resistance in the BMR is mediated by retrotransposable elements (RTEs). BMR cells and tissues express very low levels of DNA methyltransferase 1 (DNMT1). Upon cell hyperplasia, the BMR genome DNA loses methylation, resulting in activation of RTEs. Up-regulated RTEs form cytoplasmic RNA/DNA hybrids, which activate cGAS-STING pathway to induce cell death. Although this mechanism is enhanced in the BMR, we show that it functions in mice and human. We propose that RTEs were coopted to serve as tumor suppressors that monitor cell proliferation and are activated in premalignant cells to trigger cell death via activation of innate immune response. RTEs activation is a double-edged sword, serving as a tumor suppressor but in late life contributing to aging via induction of sterile inflammation. |
format | Online Article Text |
id | pubmed-8488014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-84880142022-03-23 Transposon-triggered innate immune response confers cancer resistance to the blind mole rat Zhao, Yang Oreskovic, Ena Zhang, Quanwei Lu, Quan Gilman, Abbey Lin, Yifei S. He, Junyue Zheng, Zhizhong Lu, J. Yuyang Lee, Jina Ke, Zhonghe Ablaeva, Julia Sweet, Matthew Horvath, Steve Zhang, Zhengdong Nevo, Eviatar Seluanov, Andrei Gorbunova, Vera Nat Immunol Article Blind mole rats (BMRs) are small rodents, characterized by exceptionally long lifespan (> 21 years) and resistance to both spontaneous and induced tumorigenesis. Here we report that cancer resistance in the BMR is mediated by retrotransposable elements (RTEs). BMR cells and tissues express very low levels of DNA methyltransferase 1 (DNMT1). Upon cell hyperplasia, the BMR genome DNA loses methylation, resulting in activation of RTEs. Up-regulated RTEs form cytoplasmic RNA/DNA hybrids, which activate cGAS-STING pathway to induce cell death. Although this mechanism is enhanced in the BMR, we show that it functions in mice and human. We propose that RTEs were coopted to serve as tumor suppressors that monitor cell proliferation and are activated in premalignant cells to trigger cell death via activation of innate immune response. RTEs activation is a double-edged sword, serving as a tumor suppressor but in late life contributing to aging via induction of sterile inflammation. 2021-09-23 2021-10 /pmc/articles/PMC8488014/ /pubmed/34556881 http://dx.doi.org/10.1038/s41590-021-01027-8 Text en https://www.springernature.com/gp/open-research/policies/accepted-manuscript-termsUsers may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms |
spellingShingle | Article Zhao, Yang Oreskovic, Ena Zhang, Quanwei Lu, Quan Gilman, Abbey Lin, Yifei S. He, Junyue Zheng, Zhizhong Lu, J. Yuyang Lee, Jina Ke, Zhonghe Ablaeva, Julia Sweet, Matthew Horvath, Steve Zhang, Zhengdong Nevo, Eviatar Seluanov, Andrei Gorbunova, Vera Transposon-triggered innate immune response confers cancer resistance to the blind mole rat |
title | Transposon-triggered innate immune response confers cancer resistance to the blind mole rat |
title_full | Transposon-triggered innate immune response confers cancer resistance to the blind mole rat |
title_fullStr | Transposon-triggered innate immune response confers cancer resistance to the blind mole rat |
title_full_unstemmed | Transposon-triggered innate immune response confers cancer resistance to the blind mole rat |
title_short | Transposon-triggered innate immune response confers cancer resistance to the blind mole rat |
title_sort | transposon-triggered innate immune response confers cancer resistance to the blind mole rat |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488014/ https://www.ncbi.nlm.nih.gov/pubmed/34556881 http://dx.doi.org/10.1038/s41590-021-01027-8 |
work_keys_str_mv | AT zhaoyang transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT oreskovicena transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT zhangquanwei transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT luquan transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT gilmanabbey transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT linyifeis transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT hejunyue transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT zhengzhizhong transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT lujyuyang transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT leejina transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT kezhonghe transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT ablaevajulia transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT sweetmatthew transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT horvathsteve transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT zhangzhengdong transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT nevoeviatar transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT seluanovandrei transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat AT gorbunovavera transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat |